|
ZBTB40 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.15389999946858E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.23990000000518E-06 |
| Normal-vs-Stage2 |
5.569200E-04 |
| Normal-vs-Stage3 |
3.26810001283206E-09 |
| Normal-vs-Stage4 |
4.18879999997124E-06 |
| Stage1-vs-Stage2 |
8.689600E-01 |
| Stage1-vs-Stage3 |
1.320280E-02 |
| Stage1-vs-Stage4 |
8.443900E-02 |
| Stage2-vs-Stage3 |
1.168620E-01 |
| Stage2-vs-Stage4 |
3.460800E-01 |
| Stage3-vs-Stage4 |
7.443000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.92389999948462E-07 |
| Normal-vs-AfricanAmerican |
7.57629999958986E-07 |
| Normal-vs-Asian |
1.212270E-04 |
| Caucasian-vs-AfricanAmerican |
3.205200E-01 |
| Caucasian-vs-Asian |
6.460400E-02 |
| AfricanAmerican-vs-Asian |
4.872600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.18409999875169E-08 |
| Normal-vs-Female |
1.159660E-03 |
| Male-vs-Female |
1.800840E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.417000E-04 |
| Normal-vs-Extreme_Weight |
1.62400000003338E-07 |
| Normal-vs-Obese |
1.73411999999651E-05 |
| Normal-vs-Extreme_Obese |
1.596750E-04 |
| Normal_Weight-vs-Extreme_Weight |
4.243200E-01 |
| Normal_Weight-vs-Obese |
9.171200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.625800E-01 |
| Extreme_Weight-vs-Obese |
2.592600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.886800E-01 |
| Obese-vs-Extreme_Obese |
5.710600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.752200E-02 |
| Normal-vs-Age(41-60Yrs) |
1.350470E-04 |
| Normal-vs-Age(61-80Yrs) |
3.24169999732504E-08 |
| Normal-vs-Age(81-100Yrs) |
1.92623999999419E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.657200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.373600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.311420E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.372200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.680400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.766800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.1472000000532E-06 |
| Normal-VS-Type2 PRCC |
1.08130004949913E-09 |
| Normal-VS-KIRP CIMP |
3.66059999999946E-05 |
| Normal-VS-Unclassified PRCC |
1.080770E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.816900E-03 |
| Type1 PRCC-VS-KIRP CIMP |
7.512100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.615800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.728000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.203000E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.078200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.84989999990815E-07 |
| Normal-vs-N1 |
4.7556000026816E-08 |
| Normal-vs-N2 |
1.012480E-02 |
| N0-vs-N1 |
6.550400E-01 |
| N0-vs-N2 |
9.321200E-01 |
| N1-vs-N2 |
6.986200E-01 |
|
|
